Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MED1 overexpression effect on prostate cancer cell line
PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet
Genes up and down regulated in LNCaP cells overexpressing MED1
PubMed Full text in PMC Similar studies Analyze with GEO2R
CDK7 inhibition suppresses Castration-Resistant Prostate Cancer through MED1 inactivation
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Role for AP-1 transcription factors (c-Jun, c-Fos) in prostate cancer progression and clinical outcome of prostate tumor
PubMed Similar studies Analyze with GEO2R
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development
ChIP-Seq for Nkx3-1 in whole mouse prostate
PubMed Full text in PMC Similar studies SRA Run Selector
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer
B-Raf activation cooperates with PTEN loss to drive c-Myc expression in advanced prostate cancer
Expression data from conditional Klf5 knockout Pten-null mouse prostates
NKX3-1, a Novel Transcriptional Factor of AR, Promotes Prostate Cancer Cell Survival via RAB3B GTPase-mediated protein trafficking (mRNA)
NKX3-1, a Novel Transcriptional Factor of AR, Promotes Prostate Cancer Cell Survival via RAB3B GTPase-mediated protein trafficking
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence
Glycosylation regulates the stability of c-MYC
Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: Implications for prostate cancer progression
Jun is a key Regulator of Prostate Cancer Progression and Immune Microenvironment Dynamics
PubMed Full text in PMC Similar studies
Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple-negative breast cancer
RNA sequencing analysis of MED1-overexpression induced transcription changes in HER2+ mammary tumors
Copy number profiling of prostate cancers from 40 African American patients
Cross-Species Approach Identifies MELK as a Potential Therapeutic Target in Prostate Cancer
A Cross-Species Approach Identifies MELK as a Potential Therapeutic Target in Prostate Cancer
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on